CASE DISCUSSION
Recent Advances of Cell Based Therapies in Oncology
Presented India by Dr. Shibichakravarthy KannanViews
4,087
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
With the high therapeutic potential, Immunotherapy in Cancer is expected to become the main agenda of cancer treatment. The recent advances and research studies on Cancer have revolutionized cancer therapy by specifically targeting and destroying certain cancerous cells through the body’s own...
Case Summary
- The presentation focuses on diagnostics for immunotherapies, particularly cell-based therapies like CAR-T cells. It emphasizes the importance of understanding the tumor microenvironment, classifying tumors as "hot" (T-cell infiltrated) or "cold" (lacking immune recognition). Hot tumors tend to respond better to immunotherapy, while cold tumors pose a greater challenge.
Speaker Profile
Dr. Shibichakravarthy Kannan
Precision Oncology, Founder & CEO in Oncophenomics Inc., HyderabadDisclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.